In 2013, we changed the name of this journal to Artificial Cells, Nanomedicine and Biotechnology .Artificial Cells, Nanomedicine and Biotechnology covers the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers, stem cells and tissue engineering. Emphasis is on basic research, applied research, and clinical and industrial applications of the following topics:artificial cellsblood substitutes and oxygen therapeuticsnanotechnology, nanobiotecnology, nanomedicinetissue engineeringstem cellsbioencapsulationmicroencapsulation and nanoencapsulationmicroparticles and nanoparticlesliposomescell therapy and gene therapyenzyme therapydrug delivery systemsbiodegradable and biocompatible polymers for scaffolds and carriersbiosensorsimmobilized enzymes and their usesother biotechnological and nanobiotechnological approachesRapid progress in modern research cannot be carried out in isolation and is based on the combined use of the different novel approaches. The interdisciplinary research involving novel approaches, as discussed above, has revolutionized this field resulting in rapid developments. This journal serves to bring these different, modern and futuristic approaches together for the academic, clinical and industrial communities to allow for even greater developments of this highly interdisciplinary area.

2013年，我們將本雜志更名為“人造細胞”、“納米醫(yī)學”和“生物技術(shù)”。人工細胞、納米醫(yī)學和生物技術(shù)涵蓋了跨學科研究和應(yīng)用的前沿領(lǐng)域，將人工細胞、納米技術(shù)、納米生物技術(shù)、生物技術(shù)、分子生物學、生物封裝、新型載體、干細胞和組織工程相結(jié)合。重點是以下主題的基礎(chǔ)研究、應(yīng)用研究和臨床和工業(yè)應(yīng)用：人工細胞血液替代品和氧氣療法納米技術(shù)、納米生物技術(shù)、納米醫(yī)學組織工程干細胞生物膠囊化微膠囊化和納米封裝微粒和納米粒子脂質(zhì)體細胞療法和基因療法酶療法藥物輸送系統(tǒng)支架和載體用可生物降解和生物相容性聚合物生物傳感器固定化酶及其應(yīng)用其他生物技術(shù)和納米生物技術(shù)方法現(xiàn)代研究的快速發(fā)展不能孤立地進行，而是以各種新穎方法的綜合運用為基礎(chǔ)。如上所述，涉及新穎方法的跨學科研究已經(jīng)徹底改變了這一領(lǐng)域，并取得了快速發(fā)展。本雜志旨在將這些不同的、現(xiàn)代的和未來的方法結(jié)合在一起，為學術(shù)界、臨床界和工業(yè)界提供更大的發(fā)展空間。